BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 23548761)

  • 1. Renal involvement in AA amyloidosis: clinical outcomes and survival.
    Yilmaz M; Unsal A; Sokmen M; Kaptanogullari OH; Alkim C; Kabukcuoglu F; Ozagari A; Bor E
    Kidney Blood Press Res; 2013; 37(1):33-42. PubMed ID: 23548761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal involvement in systemic amyloidosis: an Italian collaborative study on survival and renal outcome.
    Bergesio F; Ciciani AM; Manganaro M; Palladini G; Santostefano M; Brugnano R; Di Palma AM; Gallo M; Rosati A; Tosi PL; Salvadori M;
    Nephrol Dial Transplant; 2008 Mar; 23(3):941-51. PubMed ID: 17951308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AA amyloidosis complicating the hereditary periodic fever syndromes.
    Lane T; Loeffler JM; Rowczenio DM; Gilbertson JA; Bybee A; Russell TL; Gillmore JD; Wechalekar AD; Hawkins PN; Lachmann HJ
    Arthritis Rheum; 2013 Apr; 65(4):1116-21. PubMed ID: 23280696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal amyloidosis followed more than 5 years: report of 12 cases.
    Kaaroud H; Boubaker K; Béji S; Abderrahim E; Moussa FB; Turki S; Goucha R; Hedri H; El Younsi F; Kheder A; Maiz HB
    Transplant Proc; 2004; 36(6):1796-8. PubMed ID: 15350480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcomes and survival in AA amyloidosis patients.
    Ayar Y; Ersoy A; Oksuz MF; Ocakoglu G; Vuruskan BA; Yildiz A; Isiktas E; Oruc A; Celikci S; Arslan I; Sahin AB; Güllülü M
    Rev Bras Reumatol Engl Ed; 2017; 57(6):535-544. PubMed ID: 29173691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and biochemical outcome of renal amyloidosis.
    Odabas AR; Cetinkaya R; Selcuk Y; Erman Z; Bilen H
    Int J Clin Pract; 2002 Jun; 56(5):342-4. PubMed ID: 12137441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term prognosis of AL and AA renal amyloidosis: a Japanese single-center experience.
    Ozawa M; Komatsuda A; Ohtani H; Nara M; Sato R; Togashi M; Takahashi N; Wakui H
    Clin Exp Nephrol; 2017 Apr; 21(2):212-227. PubMed ID: 27116248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Renal involvement in amyloidosis. Clinical outcomes, evolution and survival].
    Esteve V; Almirall J; Ponz E; García N; Ribera L; Larrosa M; Andreu X; García M
    Nefrologia; 2006; 26(2):212-7. PubMed ID: 16808259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secondary systemic amyloidosis: response and survival in 64 patients.
    Gertz MA; Kyle RA
    Medicine (Baltimore); 1991 Jul; 70(4):246-56. PubMed ID: 2067409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of dialytic modalities on clinical outcomes in ESRD patients with familial Mediterranean fever.
    Sahin S; Sahin GM; Ergin H; Kantarci G
    Ren Fail; 2007; 29(3):315-9. PubMed ID: 17497446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presentation and outcome of patients with systemic amyloidosis undergoing dialysis.
    Bollée G; Guery B; Joly D; Snanoudj R; Terrier B; Allouache M; Mercadal L; Peraldi MN; Viron B; Fumeron C; Elie C; Fakhouri F
    Clin J Am Soc Nephrol; 2008 Mar; 3(2):375-81. PubMed ID: 18184882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Secondary amyloidosis (AA) and renal disease].
    Torregrosa E; Hernández-Jaras J; Calvo C; Ríus A; García-Pérez H; Maduell F; Vera JM
    Nefrologia; 2003; 23(4):321-6. PubMed ID: 14558331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloidosis of the kidneys. Review of patients and literature.
    Lender M; Rosenblueth M
    S Afr Med J; 1975 May; 49(20):813-7. PubMed ID: 1154134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal involvement in systemic amyloidosis--an Italian retrospective study on epidemiological and clinical data at diagnosis.
    Bergesio F; Ciciani AM; Santostefano M; Brugnano R; Manganaro M; Palladini G; Di Palma AM; Gallo M; Tosi PL; Salvadori M;
    Nephrol Dial Transplant; 2007 Jun; 22(6):1608-18. PubMed ID: 17395661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dialysis support of patients with primary systemic amyloidosis. A study of 211 patients.
    Gertz MA; Kyle RA; O'Fallon WM
    Arch Intern Med; 1992 Nov; 152(11):2245-50. PubMed ID: 1444684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of AA amyloidosis on survival in peritoneal dialysis.
    Koc Y; Basturk T; Unsal A; Sakaci T; Ahbap E; Sinangil A; Budak SK; Sevinc M; Kayalar AO; Doner B
    Kidney Blood Press Res; 2012; 36(1):182-90. PubMed ID: 23147073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous ambulatory peritoneal dialysis in familial Mediterranean fever amyloidosis patients with end-stage renal failure: a single-centre experience from Turkey.
    Altiparmak MR; Pamuk ON; Ataman R; Serdengeçti K
    Nephron Clin Pract; 2004; 98(4):c119-23. PubMed ID: 15627789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of 121 patients with renal amyloid a amyloidosis.
    Ahbap E; Kara E; Sahutoglu T; Basturk T; Koc Y; Sakaci T; Sevinc M; Akgol C; Ucar ZA; Kayalar AO; Bayraktar F; Ozagari AA; Unsal A
    J Res Med Sci; 2014 Jul; 19(7):644-9. PubMed ID: 25364365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remission of proteinuria and preservation of renal function in patients with renal AA amyloidosis secondary to rheumatoid arthritis.
    Ueno T; Takeda K; Nagata M
    Nephrol Dial Transplant; 2012 Feb; 27(2):633-9. PubMed ID: 21771754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AA amyloidosis: Mount Sinai experience, 1997-2012.
    Bunker D; Gorevic P
    Mt Sinai J Med; 2012; 79(6):749-56. PubMed ID: 23239212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.